IL6 and depressive symptom measurement: It has been suggested that because IL-6, unlike most other cytokines, is stable in the circulation, it may be involved in some of the systemic features of COPD, and in the worsening of comorbid diseases, particularly as IL-6 may contribute to impaired endothelial cell function, insulin resistance, osteoporosis, and depression [29].